Compare SCLX & TOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | TOUR |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.1M | 57.6M |
| IPO Year | 2020 | 2014 |
| Metric | SCLX | TOUR |
|---|---|---|
| Price | $5.86 | $4.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 59.5K | 5.6K |
| Earning Date | 04-10-2026 | 06-11-2026 |
| Dividend Yield | N/A | ★ 17.12% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,253,000.00 | N/A |
| Revenue This Year | $122.52 | $17.30 |
| Revenue Next Year | $186.30 | $14.00 |
| P/E Ratio | ★ N/A | $87.34 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.20 | $0.56 |
| 52 Week High | $34.27 | $7.79 |
| Indicator | SCLX | TOUR |
|---|---|---|
| Relative Strength Index (RSI) | 33.68 | 46.69 |
| Support Level | $5.48 | $4.93 |
| Resistance Level | $7.77 | $5.32 |
| Average True Range (ATR) | 0.42 | 0.11 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 13.24 | 18.60 |
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. The company offers a large selection of packaged tours, including organized tours and self-guided tours, and travel-related services for leisure travellers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.